High Rx costs are no new thing. But pharmaceutical execs actually copping to it? It happened yesterday. In a hearing in D.C., senators grilled top executives from pharma companies about list prices of medications, some of which can be life-saving for patients.
A study confirms the cost of treating someone who has more than one chronic medical condition is higher than the cost of treating each condition separately.
The United States continues to spend more per capita on health care than any other developed country — not for better medical care, because of higher prices.